MLAB - メサ・ラボラトリ―ズ （Mesa Laboratories Inc.）

https://www.investing.com/news/pro/mesa-laboratories-receives-investment-bank-analyst-rating-update-3093993

Mesa Laboratories press release (MLAB): Q1 GAAP EPS of $0.11 misses by $0.26.Revenue of $55.59M (+10.2% Y/Y) misses by $2.46M.

LAKEWOOD, Colo. (AP) — LAKEWOOD, Colo. (AP) — Mesa Laboratories Inc. (MLAB) on Thursday reported profit of $611,000 in its…

Mesa Laboratories (NASDAQ: MLAB ) reported its Q4 earnings results on Thursday, May 25, 2023 at 08:00 AM. Here''s what investors need to know about the announcement. Earnings Mesa Laboratories beat estimated earnings by 424.32%, reporting an EPS of $1.94 versus an … Full story available on Benzinga.com

LAKEWOOD, Colo., May 25, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q23”) and fiscal year (“FY23”) ended March 31, 2023.

In Q3, Mesa Laboratories reported mixed results throughout the P&L with soft bottom-line fundamentals. See why MLAB stock is a Hold.

Pulled from Benzinga Pro data, Mesa Laboratories (NASDAQ: MLAB ) posted Q3 earnings of $451 thousand, an increase from Q2 of 65.47%. Sales dropped to $54.29 million, a 7.6% decrease between quarters. In Q2, Mesa Laboratories earned $1.31 million, and total sales reached $58.75 million. Why Is ROIC Significant? Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company''s ROIC. A higher ROIC is generally representative of successful growth of a company and … Full story available on Benzinga.com

https://www.investing.com/news/pro/mesa-laboratories-pt-raised-to-180-at-evercore-isi-432SI-2996388

Mesa Laboratories press release (MLAB): Q3 Non-GAAP EPS of $2.35 beats by $0.77.Revenue of $54.29M (-0.7% Y/Y) misses by $2.76M.

Companies Reporting Before The Bell • Cummins (NYSE: CMI ) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion. • ON Semiconductor (NASDAQ: ON ) is expected to report quarterly earnings at $1.27 per share on revenue of $2.08 billion. • Neurocrine Biosciences (NASDAQ: NBIX ) is likely to report quarterly earnings at $1.14 per share on revenue of $409.09 million. • Affiliated Managers Group (NYSE: AMG ) is projected to report quarterly earnings at $7.06 per share on revenue of $589.28 million. • Tyson Foods (NYSE: TSN ) is expected to report quarterly earnings at $1.36 per share on revenue of $13.52 billion. • Energizer Hldgs (NYSE: ENR ) is estimated to report quarterly earnings at $0.76 per share on revenue of $785.86 million. • IDEXX Laboratories (NASDAQ: IDXX ) is projected to report quarterly earnings at $1.94 per share on revenue of $820.91 million. • CNA Financial (NYSE: CNA ) is estimated to report quarterly earnings at $0.97 per share on revenue of $2.28 billion. • NAPCO Security Techs (NASDAQ: NSSC ) is expected to report quarterly earnings at $0.14 per share on revenue of $39.14 million. • Daseke (NASDAQ: DSKE ) is estimated to report quarterly earnings at $0.06 per share on revenue of $397.07 million. • Loews (NYSE: L ) is projected to report earnings for its fourth quarter. • Alico (NASDAQ: ALCO ) is likely to report quarterly loss at $0.31 per share on revenue of $8.10 million. • Graham (NYSE: GHM ) is estimated to report quarterly loss at $0.10 per share on revenue of $30.00 million. • Timken (NYSE: TKR ) is expected to report quarterly earnings at $1.09 per share on revenue of $1.09 billion. • ORIX (NYSE: IX ) is estimated to report earnings for its third quarter. • Mesa Laboratories (NASDAQ: MLAB ) is likely to report quarterly earnings at $0.14 per share on revenue of $57.74 million.

Mesa Laboratories (NASDAQ: MLAB ) reported its Q4 earnings results on Tuesday, May 31, 2022 at 08:00 AM. Here''s what investors need to know about the announcement. Earnings Mesa Laboratories beat estimated earnings by 362.5%, reporting an EPS of $2.22 versus … Full story available on Benzinga.com

Mesa Laboratories press release (MLAB): Q4 GAAP EPS of -$0.34 misses by $0.82.Revenue of $58.88M (+55.1% Y/Y) beats by $2.58M.

Mesa Laboratories (MLAB) had declared $0.16/share quarterly dividend, in line with previous. Payable June 15; for shareholders of record May 31; ex-div May 27.

Mesa Laboratories press release (MLAB): Q3 Non-GAAP EPS of $1.36 beats by $0.04.Revenue of $54.69M (+60.1% Y/Y) beats by $10.22M.

Mesa Laboratories, Inc. (MLAB) shares closed today at 1.3% below its 52 week high of $333.42, giving the company a market cap of $1B. The stock is currently up 0.3% year-to-date, up 15.1% over the past 12 months, and up 170.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 71.7% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -49.8% The company's stock price performance over the past 12 months lags the peer average by -49.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -17683.1% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.